Highly selective orally active peroxisome proliferator-activated receptor (PPAR)γ
values are 8.05, < 4 and < 4 for human PPARγ
receptors respectively). Decreases glucose, fatty acid and triglyceride levels following oral administration in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold for research purposes under agreement from GlaxoSmithKline
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat.
Brown et al.
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists.
Way et al.
Potentiation of glucose uptake in 3T3-L1 adipocytes by PPARγ agonists is maintained in cells expressing a PPARγ dominant-negative mutant: evidence for selectivity in the downstream responses to PPARγ activation.
Nugent et al.
The citations listed below are publications that use Tocris products. Selected citations for GW 1929 hydrochloride include:
Showing Results 1 - 2 of 2